EDITOR'S PICKS

12
上一页 下一页
More>>
LATEST MOST VIEWED: LAST ONE YEAR MOST VIEWED: LAST TWO YEARS MOST DOWNLOADED
  • image
    Topic: How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?| Open Access

    Getting better at treating prostate cancer: what clinicians should want from scientists

    Malcolm Mason

    If the treatment landscape for prostate cancer is to be transformed, clinicians and scientists must work together ever more closely. Prostate cancer defeats physicians when patients are not accurately stratified according to patients’ risk of dying of disease, when the effects of tumor... Read more

    J Cancer Metastasis Treat 2017;3:271-7. | doi:10.20517/2394-4722.2017.51
    Published on: 17 Nov 2017  | Viewed:33  | Downloaded:4
    +HTML| PDF
  • image
    Topic: How does the prostate cancer microenvironment affect the metastatic process and/or treatment outcome?| Open Access

    Getting closer to prostate cancer in patients - what scientists should want from clinicians

    Norman J. Maitland

    For scientists pursuing drug development for prostate cancer, it is critical that an appropriate ex vivo or in vitro model system is available for study. Cancer research has generally consisted of: (1) finding the means to arrest fast growing cancer cells; or (2) (as a compromise) to slow down... Read more

    J Cancer Metastasis Treat 2017;3:262-70. | doi:10.20517/2394-4722.2017.23
    Published on: 17 Nov 2017  | Viewed:26  | Downloaded:2
    +HTML| PDF
  • image
    Topic: Cancer Immunotherapy| Open Access

    Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead

    Stanley J. Oiseth , Mohamed S. Aziz

    The knowledge that the body possesses natural defenses to combat cancer existed long before the modern period, with multiple anecdotal reports of tumors miraculously disappearing, sometimes spontaneously or after a febrile or infectious episode. Spontaneous tumor regression of untreated malignant... Read more

    J Cancer Metastasis Treat 2017;3:250-61. | doi:10.20517/2394-4722.2017.41
    Published on: 31 Oct 2017  | Viewed:813  | Downloaded:723
    +HTML| PDF
  • image
    Topic: Cancer Immunotherapy| Open Access

    Cell-mediated immunotherapy for hepatocellular carcinoma

    Wei-Chen Lee

    Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Most of the time, these tumors are diagnosed at late stages. Because no effective treatments exist for patients with advanced stage HCC, there is an urgent need for novel, effective treatments. Cancer cells originate as a... Read more

    J Cancer Metastasis Treat 2017;3:244-9. | doi:10.20517/2394-4722.2017.48
    Published on: 31 Oct 2017  | Viewed:159  | Downloaded:9
    +HTML| PDF
  • image
    Topic: Cancer Immunotherapy| Open Access

    Immunological aspect of the liver and metastatic uveal melanoma

    Mizue Terai , Michael J. Mastrangleo , Takami Sato

    Uveal (eye) melanoma is the most common primary eye malignancy in adults. Despite optimal treatments for primary uveal melanoma, up to 50% of patients subsequently develop systemic metastasis, often in the liver. Once hepatic metastasis develops, the survival of patients is generally short and... Read more

    J Cancer Metastasis Treat 2017;3:231-43. | doi:10.20517/2394-4722.2017.39
    Published on: 31 Oct 2017  | Viewed:184  | Downloaded:27
    +HTML| PDF
  • image
    Topic: Cancer Immunotherapy| Open Access

    Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery

    Yohsuke Yagawa , Keishi Tanigawa , Yasunobu Kobayashi , Masakazu Yamamoto

    Hyperthermia is a type of medical modality for cancer treatment using the biological effect of artificially induced heat. Even though the intrinsic effects of elevated body temperature in cancer tissues are poorly understood, increasing the temperature of the body has been recognized as a popular... Read more

    J Cancer Metastasis Treat 2017;3:218-30. | doi:10.20517/2394-4722.2017.35
    Published on: 31 Oct 2017  | Viewed:150  | Downloaded:20
    +HTML| PDF
  • image
    Topic: Cancer Immunotherapy| Open Access

    Introduction to the Special Issue on Cancer Immunotherapy

    Shuen-Kuei Liao J Cancer Metastasis Treat 2017;3:217. | doi:10.20517/2394-4722.2017.21
    Published on: 31 Oct 2017  | Viewed:137  | Downloaded:25
    +HTML| PDF
  • image
    Original Article| Open Access

    Health-related quality of life and its correlates among rectal cancer survivors, Northwest of Iran

    Nayyereh Aminisani , Mehdi Fatemi , Parvin Sarbakhsh , Alireza Nikanfar , Amirtaher Eftekharsadat , Esmat Jafari

    Aim: The objective of this study was to examine the health-related quality of life (HRQOL), and its correlates among rectal cancer survivors in northwest of Iran. Methods: This cross-sectional study was conducted in northwest of Iran. Rectal cancer survivors were selected from teaching hospitals.... Read more

    J Cancer Metastasis Treat 2017;3:209-16. | doi:10.20517/2394-4722.2017.47
    Published on: 29 Sep 2017  | Viewed:261  | Downloaded:16
    +HTML| PDF
  • image
    Review| Open Access

    Using circulating tumor cells to advance precision medicine in prostate cancer

    Giuseppe Galletti , Daniel Worroll , David M. Nanus , Paraskevi Giannakakou

    The field of circulating tumor cell (CTC) enrichment has seen many emerging technologies in recent years, which have resulted in the identification and monitoring of clinically relevant, CTC-based biomarkers that can be analyzed routinely without invasive procedures. Several molecular platforms... Read more

    J Cancer Metastasis Treat 2017;3:190-205. | doi:10.20517/2394-4722.2017.45
    Published on: 27 Sep 2017  | Viewed:608  | Downloaded:35
    +HTML| PDF
  • image
    Commentary| Open Access

    Adenosine A2B receptor: novel anti-cancer therapeutic implications

    Silvia Paola Corona , Navid Sobhani , Daniele Generali J Cancer Metastasis Treat 2017;3:206-8. | doi:10.20517/2394-4722.2017.50
    Published on: 27 Sep 2017  | Viewed:380  | Downloaded:20
    +HTML| PDF
+MoreView all articles
Subscribe

To receive email updates about the journal, please subscribe here.

Partners
News More>>
Quick Links
  • OAE Publishing Inc. (OAE) is an online open-access publisher specializing in the publication of biomedical peer-reviewed journals...

  • Contact us
  • Leave feedback
Partners
Copyright © 2017 OAE Publishing Inc. All Rights Reserved.